Currently Used Low-Dose Pyrazinamide Does Not Increase Liver-Injury in the First Two Months of Tuberculosis Treatment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Currently Used Low-Dose Pyrazinamide Does Not Increase Liver-Injury in the First Two Months of Tuberculosis Treatment

Published:2015 Issue:18 Volume:54 Page:2315-2320
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Horita Nobuyuki¹,Miyazawa Naoki²,Yoshiyama Takashi³,Kojima Ryota¹,Ishigatsubo Yoshiaki⁴,Kaneko Takeshi¹

Affiliation:

1. Department of Pulmonology, Yokohama City University Graduate School of Medicine, Japan

2. Department of Respiratory Medicine, Saiseikai Yokohamashi Nanbu Hospital, Japan

3. Division of Respiratory Medicine, Japan-antituberculosis Association Fukujuji Hospital, Japan

4. Department of Internal Medicine and Clinical Immunology, Yokohama City University Graduate School of Medicine, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/54/18/54_54.5533/_pdf

Reference20 articles.

1. 1. Blumberg HM, Burman WJ, Chaisson RE, et al. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. Am J Respir Crit Care Med 167: 603-662, 2003.

2. 2. Steele MA, Des Prez RM. The role of pyrazinamide in tuberculosis chemotherapy. Chest 94: 845-850, 1988.

3. 3. British Thoracic Association. A controlled trial of six months chemotherapy in pulmonary tuberculosis. First Report: results during chemotherapy. Br J Dis Chest 75: 141-153, 1981.

4. 4. Hong Kong Chest Service/British Medical Research Council. Controlled trial of 4 three-times-weekly regimens and a daily regimen all given for 6 months for pulmonary tuberculosis. Second report: the results up to 24 months. Tubercle 63: 89-98, 1982.

5. 5. Hong YP, Kim SC, Chang SC, Kim SJ, Jin BW, Park CD. Comparison of a daily and three intermittent retreatment regimens for pulmonary tuberculosis administered under programme conditions. Tubercle 69: 241-253, 1988.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety of pyrazinamide in elderly patients with tuberculosis in Japan: A nationwide cohort study;Respirology;2024-05-21

2. Impact of Pyrazinamide Usage on Serious Adverse Events in Elderly Tuberculosis Patients: A Multicenter Cohort Study;2024-03-29

3. Predicting Antituberculosis Drug–Induced Liver Injury Using an Interpretable Machine Learning Method: Model Development and Validation Study;JMIR Medical Informatics;2021-07-20

4. Predicting Antituberculosis Drug–Induced Liver Injury Using an Interpretable Machine Learning Method: Model Development and Validation Study (Preprint);2021-03-30

5. Safety of Pyrazinamide for the Treatment of Tuberculosis in Older Patients Over 75 Years of Age: A Retrospective Monocentric Cohort Study;Drugs & Aging;2020-11-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3